Nail psoriasis improvement in a patient treated with fumaric acid esters

Journal of Dermatological Treatment

Volumn 18, Issue 3, 2007, Pages 175-177

  Vlachou, Christina ^a   Berth Jones, John ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

Fumaric acid esters; Nail psoriasis

Indexed keywords

CLOBETASOL PROPIONATE; CYCLOSPORIN; FUMADERM; PSORALEN; TACROLIMUS;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; DISTRESS SYNDROME; DRUG EFFICACY; EOSINOPHILIA; FLUSHING; HUMAN; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGICAL ASPECT; SIDE EFFECT;

ADULT; DERMATOLOGIC AGENTS; FUMARATES; HUMANS; MALE; NAIL DISEASES; PSORIASIS;

EID: 34249779833     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701264331     Document Type: Article

References (11)

1. De Jong EM, Seegers BA, Gulnick MD, Boezeman JB, van de Kerkhof PC. Psoriasis of the nail associated with disability in a large number of patients: Results of a recent interview with 1,728 patients. Dermatology. 1996;193:300-3.
2. De Berker D. Management of nail psoriasis. Clin Exp Dermatol. 2000;25:357-62.
3. Nandedkar-Thomas MA, Scher RK. An update on disorders of the nails. J Am Acad Dermatol. 2005;52:877-87.
4. Bianchi L, Bergamin A, de Felice C, Capriotti E, Chimenti S. Remission and time resolution of nail psoriasis during infliximab therapy. J Am Acad Dermatol. 2005;52:736-7.
5. Rich P, Scher RK. Nail psoriasis severity index: A useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49:206-12.
6. Cassetty CT, Alexis AF, Shupack JL, Strober BE. Alefacept in the treatment of psoriatic nail disease: A small case series. J Am Acad Dermatol. 2005;52:1101-2.
7. Ormerod AD, Mrowietz U. Fumaric acid esters, their place in the treatment of psoriasis. Br J Dermatol. 2004;150:630-2.
8. Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P, et al. Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol. 1994;30:977-81.
9. Kolbach DN, Nieboer C. Fumaric acid therapy in psoriasis: Results and side-effects of 2 years of treatment. J Am Acad Dermatol. 1992;27:769-71.
10. Mrowietz U, Christophers E, Altmeyer P. Treatment of psoriasis with fumaric acid esters: Results of a prospective multicenter study. Br J Dermatol. 1998;138:456-60.
11. Balasubramaniam P, Stevenson O, Berth-Jones J. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities. Br J Dermatol. 2004;150:741-6.